Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.

导出 OA

翻译打印收藏纠错

作者： Atsushi,Hiraoka ^[1] ; Takashi,Kumada ^[2] ; Kazuya,Kariyama ^[2] ; Hidenori,Toyoda ^[3] ; Satoshi,Yasuda ^[2] ; Kunihiko,Tsuji ^[4] ; Takeshi,Hatanaka ^[2] ; Satoru,Kakizaki ^[5] ; Atsushi,Naganuma ^[2] ; Toru,Ishikawa ^[5] ; Toshifumi,Tada ^[2] ; Koichi,Takaguchi ^[6] ; Ei,Itobayashi ^[2] ; Noritomo,Shimada ^[7] ; Hiroshi,Shibata ^[2] ; Takaaki,Tanaka ^[8] ; Akemi,Tsutsui ^[2] ; Takuya,Nagano ^[9] ; Michitaka,Imai ^[2] ; Shinichiro,Nakamura ^[10] ; Kazuhiro,Nouso ^[2]

作者单位： Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan. ^[1] Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan. ^[2] Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan. ^[3] Department of Gastroenterology, Okayama City Hospital, Okayama, Japan. ^[4] Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan. ^[5] Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan. ^[6] Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Gunma, Japan. ^[7] Department of Clinical Research, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan. ^[8] Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan. ^[9] Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan. ^[10]

关键词 Barcelona Clinic Liver Cancer-B hepatocellular carcinoma Concept of Indication of TACE Reframing Un-Suitable condition to Manage Intermediate stage liver CANcer score Transcatheter arterial chemoembolization refractoriness Transcatheter arterial chemoembolization unsuitable Tumor marker score